Expression of long non-coding RNA in peripheral blood of patients with esophageal squamous cell carcinoma

胡云,曹秀峰,唐薇薇

DOI: https://doi.org/10.3760/cma.j.cn421213-20190718-01011

2020-01-01

Abstract:Objective:To investigate the expression and significance of long non-coding RNA (lncRNA) in peripheral blood of patients with esophageal squamous cell carcinoma (ESCC).Methods:Five serum samples in early-stage (Ⅰ-Ⅱ) ESCC patients (case group 1), mediate-late-stage (Ⅲ-Ⅳ) ESCC patients (case group 2), and normal adult (control group) each from June 2015 to December 2018 in Nanjing First Hospital were collected. Total RNA was extracted using TRIzol reagent and transcribed. The obtained cRNA was used as a template for reverse transcription to synthesize cDNA. After purification, it was fluorescently labeled and hybridized with lncRNA chip. Pairwise comparisons screened out lncRNAs whose relative expression ratio was more than 2 times and the differences were statistically significant as differentially expressed lncRNAs. Real-time fluorescence quantitative PCR (RT-qPCR) was used to verify the expression of lnc_TCONS_00011689 in ESCC samples, and to analyze its relationship with the clinicopathological characteristics and prognosis of ESCC patients. The follow-up date ended December 31, 2019. GraphPad Prism 5.0 statistical software was used for analysis and paired t test and Log-rank survival analysis were applied. Results:In the case group 1 vs. control group, 1620 lncRNAs were up-regulated and 102 lncRNAs were down-regulated. In the case group 2 vs. control group, 17 lncRNAs were up-regulated and 129 lncRNAs were down-regulated. In the case group 2 vs. case group 1, 9 lncRNAs were up-regulated and 73 lncRNAs were down-regulated. Analysis of bioinformatics data shows that the functions of these differentially expressed genes are related to the functions of cell interaction, metabolism, immune response, and cell adhesion molecules ( r>0.99, P<0.05). The co-expression analysis of differentially expressed lncRNAs and differentially expressed mRNAs in different groups showed that the top 1 000 relationships were the most relevant in the expression results ( r>0.99, P<0.05). The expression of lnc_TCONS_00011689 in plasma of ESCC patients was significantly lower than that in normal people, and it was significantly correlated with clinical stage and prognosis ( P<0.05). Conclusion:This study established differential lncRNA expression profiles in peripheral blood of ESCC patients with different stages. Lnc_TCONS_00011689 can be used as a molecular marker for the diagnosis, staging and prognosis of ESCC.